I have posted the facts about the patents. Nothing should be confusing to anyone reading my posts.
Radient has two approved patents for DR70. One has already expired and the second will expire in just over a month.
Radient has one patent application that is in the pool for review which will take years. The application was rejected for "prior art". Smith-Howard argued that the GenWay art was not applicable but did nothing to refute the other prior art but to state that is was not applicable also.
Gartner has filed no patents on the DR70/LC Sentinel lung cancer test. There is nothing in the European database, the USA database nor the PCT WIPA filing system. Any filing he might make about DR70 and lung cancer would certainly be ruled "prior art" because of all the disclosures by Radient and the fact that it was approved by Health Canada for lung cancer testing already.
I have never shorted nor intend to have any financial interest in this stock. I am not connected with anyone who trades, shorts or has financial interests in this stock. I only post facts and my opinions. I do not post on IHUB with different aliases.
